These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 15375563)
1. Construction and expression of a bispecific single-chain antibody that penetrates mutant p53 colon cancer cells and binds p53. Weisbart RH; Wakelin R; Chan G; Miller CW; Koeffler PH Int J Oncol; 2004 Oct; 25(4):1113-8. PubMed ID: 15375563 [TBL] [Abstract][Full Text] [Related]
2. Combining intracellular antibodies to restore function of mutated p53 in cancer. Chan G; Jordaan G; Nishimura RN; Weisbart RH Int J Cancer; 2016 Jan; 138(1):182-6. PubMed ID: 26174762 [TBL] [Abstract][Full Text] [Related]
3. Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments. Caron de Fromentel C; Gruel N; Venot C; Debussche L; Conseiller E; Dureuil C; Teillaud JL; Tocque B; Bracco L Oncogene; 1999 Jan; 18(2):551-7. PubMed ID: 9927212 [TBL] [Abstract][Full Text] [Related]
4. Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53. Abarzúa P; LoSardo JE; Gubler ML; Neri A Cancer Res; 1995 Aug; 55(16):3490-4. PubMed ID: 7627952 [TBL] [Abstract][Full Text] [Related]
5. Single chain antibody against the common epitope of mutant p53 restores wild-type activity to mutant p53 protein. Orgad S; Goldfinger N; Cohen G; Rotter V; Solomon B FEBS Lett; 2005 Oct; 579(25):5609-15. PubMed ID: 16213502 [TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated p53 protein therapy prevents liver metastasis in vivo. Hansen JE; Fischer LK; Chan G; Chang SS; Baldwin SW; Aragon RJ; Carter JJ; Lilly M; Nishimura RN; Weisbart RH; Reeves ME Cancer Res; 2007 Feb; 67(4):1769-74. PubMed ID: 17308119 [TBL] [Abstract][Full Text] [Related]
7. Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells. Cho BK; Roy EJ; Patrick TA; Kranz DM Bioconjug Chem; 1997; 8(3):338-46. PubMed ID: 9177839 [TBL] [Abstract][Full Text] [Related]
8. Antibody-mediated transduction of p53 selectively kills cancer cells. Weisbart RH; Hansen JE; Chan G; Wakelin R; Chang SS; Heinze E; Miller CW; Koeffler PH; Yang F; Cole GM; Min YS; Nishimura RN Int J Oncol; 2004 Dec; 25(6):1867-73. PubMed ID: 15547728 [TBL] [Abstract][Full Text] [Related]
9. [Construction and characterization of bispecific single-chain antibody fragments SZ-2/SZ-21 against platelet glycoprotein Ib alpha and beta3]. Dai K; An G; Ruan C Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1493-7. PubMed ID: 12509914 [TBL] [Abstract][Full Text] [Related]
10. Characterization of scFv-421, a single-chain antibody targeted to p53. Jannot CB; Hynes NE Biochem Biophys Res Commun; 1997 Jan; 230(2):242-6. PubMed ID: 9016757 [TBL] [Abstract][Full Text] [Related]
11. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2. Biburger M; Weth R; Wels WS J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482 [TBL] [Abstract][Full Text] [Related]
12. Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes. Connelly RJ; Hayden MS; Scholler JK; Tsu TT; Dupont B; Ledbetter JA; Kanner SB Int Immunol; 1998 Dec; 10(12):1863-72. PubMed ID: 9885907 [TBL] [Abstract][Full Text] [Related]
13. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein. Pavoni E; Flego M; Dupuis ML; Barca S; Petronzelli F; Anastasi AM; D'Alessio V; Pelliccia A; Vaccaro P; Monteriù G; Ascione A; De Santis R; Felici F; Cianfriglia M; Minenkova O BMC Cancer; 2006 Feb; 6():41. PubMed ID: 16504122 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies. Wang X; Campoli M; Ko E; Luo W; Ferrone S J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic antibody fragments for eliminating undifferentiated human embryonic stem cells. Lim DY; Ng YH; Lee J; Mueller M; Choo AB; Wong VV J Biotechnol; 2011 May; 153(3-4):77-85. PubMed ID: 21458505 [TBL] [Abstract][Full Text] [Related]
16. Antineoplastic effect of intracellular expression of a single-chain antibody directed against type IV collagenase. Wang W; Zhou J; Xu L; Zhen Y J Environ Pathol Toxicol Oncol; 2000; 19(1-2):61-8. PubMed ID: 10905509 [TBL] [Abstract][Full Text] [Related]
17. An autoantibody is modified for use as a delivery system to target the cell nucleus: therapeutic implications. Weisbart RH; Stempniak M; Harris S; Zack DJ; Ferreri K J Autoimmun; 1998 Oct; 11(5):539-46. PubMed ID: 9802941 [TBL] [Abstract][Full Text] [Related]
18. Improved antigen binding by a CD20-specific single-chain antibody fragment with a mutation in CDRH1. Adamson PJ; Millard DJ; Hohmann AW; Mavrangelos C; Macardle PJ; Pilkington G; Mulhern TD; Tedder TF; Zola H; Nicholson IC Mol Immunol; 2006 Feb; 43(6):550-8. PubMed ID: 15936081 [TBL] [Abstract][Full Text] [Related]
19. A tumor specific single chain antibody dependent gene expression system. Mary MN; Venot C; Caron de Fromentel C; Debussche L; Conseiller E; Cochet O; Gruel N; Teillaud JL; Schweighoffer F; Tocque B; Bracco L Oncogene; 1999 Jan; 18(2):559-64. PubMed ID: 9927213 [TBL] [Abstract][Full Text] [Related]
20. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen. Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]